Prior studies on NSAIDS and glioma, including one study using CPRD data [34], reported null [34–38], inverse [39–42], or positive [43, 44] associations, but those studies did not examine the effect of selective COX-2 inhibitors specifically. Here, PTGS2 is linked to central nervous system cancer.